On February 26, 2020 DURECT Corporation (Nasdaq: DRRX) reported that it will report its fourth quarter and year ended December 31, 2019 financial results and host a conference call after the market close on Tuesday, March 3, 2020 (Press release, DURECT, FEB 26, 2020, https://investors.durect.com/news-releases/news-release-details/durect-corporation-announce-2019-financial-results-march-3 [SID1234554818]).
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Tuesday March 3rd @ 4:30pmET/1:30 p.m. Pacific Time
Toll Free:
877-407-0784
International:
201-689-8560
Conference ID:
13698601
Webcast: